Vitrolife AB (publ)

Stockholm Stock Exchange VITR.ST

Vitrolife AB (publ) Gross Profit Margin for the year ending December 31, 2023: 56.32%

Vitrolife AB (publ) Gross Profit Margin is 56.32% for the year ending December 31, 2023, a 2.33% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Vitrolife AB (publ) Gross Profit Margin for the year ending December 31, 2022 was 55.04%, a -11.56% change year over year.
  • Vitrolife AB (publ) Gross Profit Margin for the year ending December 31, 2021 was 62.24%, a 0.98% change year over year.
  • Vitrolife AB (publ) Gross Profit Margin for the year ending December 31, 2020 was 61.63%, a -2.81% change year over year.
  • Vitrolife AB (publ) Gross Profit Margin for the year ending December 31, 2019 was 63.42%, a -4.07% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Stockholm Stock Exchange: VITR.ST

Vitrolife AB (publ)

CEO Ms. Bronwyn Brophy O´Connor
IPO Date June 28, 2001
Location Sweden
Headquarters Gustaf Werners gata 2
Employees 1,111
Sector Health Care
Industries
Biotechnology Medical Instruments Pharmaceuticals
Description

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.

StockViz Staff

January 15, 2025

Any question? Send us an email